Zogenix, Inc. Careers Where MEDICINE Meets TECHNOLOGY About Zogenix Responsibility Products Pipeline Technology Newsroom Investors Contact 1 2 3 4 Latest News Zogenix Viewpoints Technology 10-01-14 Zogenix Submits Modified Formulation of Zohydro(R) ER With Potential Abuse Deterrent Properties for FDA Review 09-18-14 New Data Shows Zohydro(R) ER Reduced Pain and Improved Function in People With Chronic Pain 09-04-14 Education, Patient-Focused Approach to Treating Chronic Pain Are Keys to Preventing Opioid Abuse, Say Experts, Patients Now Is the Time for Collaboration on a Comprehensive Approach to Address Nation’s Opioid Abuse Epidemic Voices of the Patient: Christopher Phillips Voices of the Patient: Mark Maginn Voices of the Patient: Gina Libby DosePro is a first-in-class, easy-to-use drug delivery system designed for self-administration of a pre-filled, single dose of liquid drug, subcutaneously, without a needle. DosePro offers benefits to patients including instant, easy dosing, less anxiety over self-injection, no need for sharps disposal, no risk of needle stick injury or contamination, and reliable performance. Copyright © 2014 Zogenix, Inc. All rights reserved. Privacy | Responsibility | Terms of Use ABOUT ZOGENIX Introduction Executive Team Board of Directors Careers Contact Us RESPONSIBILITY PRODUCTS Zohydro ER SUMAVEL DosePro PIPELINE Overview Relday TECHNOLOGY DosePro Technology Applications Manufacturing Partnering News & Publications NEWSROOM Press Releases Publications and Posters Media Kit and Library Zogenix Viewpoints INVESTORS CONTACT